Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Syva is a pioneering diagnostics company that revolutionized the field of toxicology and therapeutic drug monitoring. Founded in 1966 as a joint venture between Syntex and Varian Associates, the company developed the Enzyme Multiplied Immunoassay Technique (EMIT), which became the industry standard for rapid drug screening. Currently operating as a key brand within Siemens Healthineers, Syva provides high-performance assays for detecting illicit substances and monitoring critical medication levels. Its product portfolio is extensively used in clinical laboratories, hospitals, and forensic settings worldwide. Syva's commitment to accuracy and efficiency continues to support healthcare providers and law enforcement in managing substance abuse and patient care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Syva.